Evidence map›Paper›PMID 33664266›Full record

ArticleNature communications2021

Enzymatic spiroketal formation via oxidative rearrangement of pentangular polyketides.

Britta Frensch, Thorsten Lechtenberg, Michel Kather, Zeynep Yunt, Martin Betschart, Bernd Kammerer, Steffen Lüdeke, Michael Müller, Jörn Piel, Robin Teufel

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Catalytic Control of Spiroketal Formation in Rubromycin Polyketide Biosynthesis.Angewandte Chemie (International ed. in English) · 2021
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Britta FrenschFaculty of Biology, University of Freiburg, Schänzlestrasse 1, 79104, Freiburg, Germany.ORCID 0000-0001-8756-4842
Thorsten LechtenbergFaculty of Biology, University of Freiburg, Schänzlestrasse 1, 79104, Freiburg, Germany.
Michel KatherBIOSS Center for Biological Signaling Studies, University of Freiburg, 79104, Freiburg, Germany.
Zeynep YuntDepartment of Molecular Biology and Genetics, Koç University, Istanbul, 34450, Turkey.
Martin BetschartInstitute of Pharmaceutical Sciences, University of Freiburg, 79104, Freiburg, Germany.
Bernd KammererBIOSS Center for Biological Signaling Studies, University of Freiburg, 79104, Freiburg, Germany.
Steffen LüdekeInstitute of Pharmaceutical Sciences, University of Freiburg, 79104, Freiburg, Germany.ORCID 0000-0003-1498-5552
Michael MüllerInstitute of Pharmaceutical Sciences, University of Freiburg, 79104, Freiburg, Germany.ORCID 0000-0002-2742-4992
Jörn PielInstitute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, 8093, Zürich, Switzerland.ORCID 0000-0002-2282-8154
Robin TeufelFaculty of Biology, University of Freiburg, Schänzlestrasse 1, 79104, Freiburg, Germany. robin.teufel@zbsa.uni-freiburg.de.ORCID 0000-0001-5863-7248
University of Freiburg · DEBoard of the Swiss Federal Institutes of Technology · CHKoç University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The structural complexity and bioactivity of natural products often depend on enzymatic redox tailoring steps. This is exemplified by the generation of the bisbenzannulated [5,6]-spiroketal pharmacophore in the bacterial rubromycin family of aromatic polyketides, which exhibit a wide array of bioactivities such as the inhibition of HIV reverse transcriptase or DNA helicase. Here we elucidate the complex flavoenzyme-driven formation of the rubromycin pharmacophore that is markedly distinct from conventional (bio)synthetic strategies for spiroketal formation. Accordingly, a polycyclic aromatic precursor undergoes extensive enzymatic oxidative rearrangement catalyzed by two flavoprotein monooxygenases and a flavoprotein oxidase that ultimately results in a drastic distortion of the carbon skeleton. The one-pot in vitro reconstitution of the key enzymatic steps as well as the comprehensive characterization of reactive intermediates allow to unravel the intricate underlying reactions, during which four carbon-carbon bonds are broken and two CO

Indexed as

Anti-Bacterial AgentsBiological ProductsDNA HelicasesFuransHIV Reverse TranscriptaseMixed Function OxygenasesOxidation-ReductionPolyketidesSpiro CompoundsAnti-Bacterial AgentsBiological ProductsDNA HelicasesFuransHIV Reverse TranscriptaseMixed Function OxygenasesPolyketidesSpiro Compoundsspiroketal

Identifiers

PMID33664266
PMCPMC7933358
OpenAlexW3134554755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.